Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYF5 |
| Upstream (Parents) |
|---|
| (<<) IKZF3 → MYF5 |
| (<<) MYT1L → MYF5 |
| (<<) ZSCAN12 → MYF5 |
| (<<) VENTX → MYF5 |
| (<<) TFAP2A → MYF5 |
| (<<) TADA3 → MYF5 |
| (<<) FOXH1 → MYF5 |
| (<<) TP73 → MYF5 |
| (<<) PHF1 → MYF5 |
| (<<) FOXE3 → MYF5 |
| (<<) STAT1 → MYF5 |
| (<<) DBP → MYF5 |
| (<<) SRF → MYF5 |
| Downstream (Children) |
|---|
| MYF5 → RUNX1 (>>) |
| MYF5 → TLX3 (>>) |
| MYF5 → RCAN1 (>>) |
| MYF5 → ELK1 (>>) |
| MYF5 → PPARD (>>) |
| MYF5 → POU3F2 (>>) |
| MYF5 → HAND2 (>>) |
| MYF5 → PDX1 (>>) |
| MYF5 → NFATC1 (>>) |
| MYF5 → RXRG (>>) |
